DLG4 Gene (PSD-95): Synaptic Scaffolding Protein and Its Role in Neurodevelopmental Disorders
Comprehensive genetic and functional annotation of DLG4, encoding postsynaptic density protein 95 (PSD-95), a key regulator of synaptic plasticity and a candidate gene for intellectual disability and schizophrenia.
Gene Information Card
| Symbol | DLG4 |
|---|---|
| Full Name | Discs Large Homolog 4 (Drosophila) |
| Gene Type | Protein coding |
| Chromosomal Location | 17p13.1 |
| NCBI Gene ID | 1742 ncbi.nlm.nih.gov/gene/1742 |
| Ensembl ID | ENSG00000132535 |
| UniProt ID | P78352 |
| OMIM ID | 602887 |
| HGNC ID | 2903 |
| Aliases | PSD95, SAP90, FLJ97752, DLG4 |
Description
The DLG4 gene encodes postsynaptic density protein 95 (PSD-95), a member of the membrane-associated guanylate kinase (MAGUK) family. PSD-95 is a critical scaffolding protein localized at excitatory glutamatergic synapses, where it organizes neurotransmitter receptors (e.g., NMDA and AMPA receptors), ion channels, and signaling molecules. It plays a central role in synaptic maturation, plasticity, and learning. De novo loss-of-function mutations in DLG4 are associated with a neurodevelopmental disorder characterized by intellectual disability, developmental delay, and behavioral abnormalities. The protein contains three PDZ domains, an SH3 domain, and a guanylate kinase (GK) domain, which mediate its interactions with a wide array of synaptic proteins.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Intellectual Developmental Disorder 62 (MRD62) | Haploinsufficiency due to de novo loss-of-function mutations (nonsense, frameshift, splice-site) leading to reduced PSD-95 protein levels and disrupted synaptic scaffolding. | ClinVar; OMIM #618793; PMID: 30323198 |
| Schizophrenia | Common genetic variants and rare copy number variations in DLG4 may alter PSD-95 expression, affecting glutamatergic signaling and synaptic connectivity in the prefrontal cortex. | GWAS; PMID: 25056061; PMID: 28138101 |
| Autism Spectrum Disorder (ASD) | Rare de novo missense and loss-of-function variants identified in ASD cohorts, suggesting a role in synaptic dysfunction underlying ASD pathophysiology. | SFARI Gene; PMID: 29276005 |
| Major Depressive Disorder (MDD) | Altered DLG4 expression and PSD-95 protein levels in the prefrontal cortex of MDD patients, potentially contributing to synaptic atrophy. | PMID: 26001636 |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Cerebral Cortex | 127.5 | High |
| Hippocampus | 118.3 | High |
| Cerebellum | 85.2 | High |
| Basal Ganglia | 62.1 | Medium |
| Spinal Cord | 45.8 | Medium |
| Testis | 12.4 | Low |
| Liver | 1.2 | Not detected |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| SH-SY5Y (Neuroblastoma) | 78.5 | High expression; used as neuronal model |
| SK-N-AS (Neuroblastoma) | 65.3 | Moderate expression |
| U-87 MG (Glioblastoma) | 42.1 | Moderate expression |
| HEK293 (Embryonic Kidney) | 3.2 | Low; often used for heterologous expression studies |
| HeLa (Cervical Carcinoma) | 1.8 | Very low; not endogenous |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.657C>A (p.Tyr219Ter) | Nonsense | Rare (de novo) | Premature stop codon; loss-of-function; associated with MRD62 |
| c.1129_1130del (p.Leu377ValfsTer5) | Frameshift | Rare (de novo) | Truncated protein; loss-of-function; associated with MRD62 |
| c.138+1G>A | Splice-site | Rare (de novo) | Aberrant splicing; loss-of-function; associated with MRD62 |
| c.466G>A (p.Asp156Asn) | Missense | Rare (de novo) | Alters PDZ1 domain; likely affects ligand binding; uncertain significance |
| c.1901C>T (p.Pro634Leu) | Missense | Rare (de novo) | Located in GK domain; may affect protein stability; uncertain significance |
Mutation functional classification
Loss of Function (LOF)
Predominant mechanism. Nonsense, frameshift, and splice-site mutations lead to nonsense-mediated decay or truncated proteins, resulting in haploinsufficiency. This disrupts the stoichiometry of the postsynaptic density and impairs synaptic transmission and plasticity.
Gain of Function (GOF)
Not well established. No clear gain-of-function mutations have been reported for DLG4 in human disease. Some missense variants may theoretically alter protein-protein interactions, but evidence is lacking.
Dominant Negative (DN)
Possible but not confirmed. Certain missense mutations in the PDZ domains could potentially interfere with the function of the wild-type protein by forming non-functional complexes, but this has not been demonstrated in vivo.
View complete mutation data:
Gene Ontology (GO)
Pathways
• Glutamatergic synapse (KEGG: hsa04724)
• Long-term potentiation (KEGG: hsa04720)
• Long-term depression (KEGG: hsa04730)
• Neuroactive ligand-receptor interaction (KEGG: hsa04080)
• Postsynaptic density protein signaling (Reactome: R-HSA-6794362)
Protein Summary
PSD-95 is a 724-amino acid protein with a molecular weight of approximately 80 kDa. It contains three N-terminal PDZ domains (PDZ1-3), an SH3 domain, and a C-terminal guanylate kinase (GK) domain. PDZ1 and PDZ2 bind to the C-termini of NMDA receptor subunits (GluN2A/B) and potassium channels (Kv1.4). PDZ3 interacts with AMPA receptor auxiliary subunits (e.g., stargazin/TARPs). The SH3-GK domain forms an intramolecular interaction that regulates protein conformation. PSD-95 is palmitoylated at N-terminal cysteines (Cys3, Cys5), which is essential for its synaptic targeting and clustering. It is a core organizer of the postsynaptic density, linking receptors to the actin cytoskeleton and downstream signaling pathways (e.g., Ras/ERK, PI3K/Akt).
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| DLG4 Knockout HEK293 Cell Line | EDJ-KQ1388 | Human | 1742 | Details Get a Quote |
| DLG4 Knockout A-549 Cell Line | EDJ-KQ20907 | Human | 1742 | Details Get a Quote |
| DLG4 Knockout HCT 116 Cell Line | EDJ-KQ20908 | Human | 1742 | Details Get a Quote |
| DLG4 Knockout HeLa Cell Line | EDJ-KQ20909 | Human | 1742 | Details Get a Quote |
Displaying Records 1 To 4 Of 4 Records